FIGNL1 is overexpressed in small cell lung cancer patients and enhances NCI-H446 cell resistance to cisplatin and etoposide | |
Ma, Jian; Li, Jianlei; Yao, Xiaoling; Lin, Shuangjun; Gu, Ye; Xi, Jianfang; Deng, Zixin; Ma, Wei; Zhang, Haiping | |
刊名 | ONCOLOGY REPORTS
![]() |
2017 | |
卷号 | 37期号:4 |
关键词 | small cell lung cancer FIGNL1 DNA repair homologous recombination repair pathway chemotherapy resistance |
ISSN号 | 1021-335X |
DOI | 10.3892/or.2017.5483 |
URL标识 | 查看原文 |
收录类别 | SCIE |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3985296 |
专题 | 武汉大学 |
推荐引用方式 GB/T 7714 | Ma, Jian,Li, Jianlei,Yao, Xiaoling,et al. FIGNL1 is overexpressed in small cell lung cancer patients and enhances NCI-H446 cell resistance to cisplatin and etoposide[J]. ONCOLOGY REPORTS,2017,37(4). |
APA | Ma, Jian.,Li, Jianlei.,Yao, Xiaoling.,Lin, Shuangjun.,Gu, Ye.,...&Zhang, Haiping.(2017).FIGNL1 is overexpressed in small cell lung cancer patients and enhances NCI-H446 cell resistance to cisplatin and etoposide.ONCOLOGY REPORTS,37(4). |
MLA | Ma, Jian,et al."FIGNL1 is overexpressed in small cell lung cancer patients and enhances NCI-H446 cell resistance to cisplatin and etoposide".ONCOLOGY REPORTS 37.4(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论